Correlation between P53 expression and CD34 angiogenic factor in Tunisian breast cancer

Tunisie Medicale

Volumn 85, Issue 2, 2007, Pages 105-108

  Fourati, Asma ^a   Khomsi, Fathi ^a   El May, Michele V ^b   Rahal, Khaled ^a   Gamoudi, Amor ^a   Boussen, Hamouda ^a   Abdallah, Mansour Ben ^a   El May, Ahmed ^a  

^a SALAH AZAIEZ INSTITUTE   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Angiogenesis; Breast carcinoma; CD34; P53

Indexed keywords

ANGIOGENIC FACTOR; CD34 ANTIGEN; PROTEIN P53;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER GRADING; CONTROLLED STUDY; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; TUNISIA; VASCULARIZATION;

ADULT; AGED; ANTIGENS, CD34; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34248545229     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Tabbane F, El May A, Bahi J et al. Breast cancer in women under 30 years of age. Breast Cancer Res Treat 1985; 6 :137.
2. Hart IR, Saini A. Biology of tumor metastasis. Lancet 1992; 339 :1453.
3. Gasparini G, Weidner N, Maluta S et al. Intratumoral microvessel density and P53 protein : correlation with metastasis in head and neck squamous cell carcinoma. Int J Cancer 1993; 55 :739.
4. Folkman J.What is the evidence that tumors are angiogenesis dependent. J Nad Cancer Inst 1990; 82 : 4.
5. Ellis L M, Fidler I J. Angiogenesis and breast cancer metastasis. Lancet 1995; 346 :388.
6. Weinder N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995; 147 :9.
7. Maccharini P, Fontanini G, Hardin MJ et al. Relation of neovascularization to metastasis of non - small -cell lung cancer. Lancet 1992; 340 :145.
8. Bosari S, Lee AK, De Lellis RA et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992; 23 :755.
9. Warnberg F, Nordgren H, Berkvist L et al. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness. Br J Cancer 2001; 85 :869.
10. Kato T, Kameoka S, Kimura T, et al. Angiogonesis and blood vessel invasion as prognostic indicators for node- negative breast cancer. Breast Cancer Res Treat 2001; 65 :203.
11. Goulding H, Nik Abdul Rashid NF, Robertson JF et al. Assessment of angiogenesis in breast carcinoma : An important factor in prognosis ? Hum Pathol 1995; 26 :1196.
12. Hall NR, Fish DE, Hunt N et al. Is the relationship between angiogenesis and metastasis in breast cancer real ? Surg Oncol 1992; 1 :223.
13. Elston CW, Ellis IO.Pathological prognostic factors in breast cancer - 1: the value of histological grade in breast cancer experience from a large study with long-term follow up. Histopathol 1991 ; 15 :403.
14. Pinder SE, Ellis IO, O' Roukes et al. athological factors in breast cancer - 3 : vascular invasion: Relationship with recurrence and survival in a large study with long-term follow up. Histopathol 1994; 24 : 41.
15. Max J. Cellular changes on the route to metastasis. Science 1993; 259 :626.
16. Hollestein M, Sidransky D, Vogelstein B et al. P 53 mutations in human cancers. Science 1991 ; 25 :49.
17. Fourati-Kharrat A, Bouraoui S, Rahal K et al. P53 and Bcl2 expression in breast cancer. Prospective study in Tunisia. Austral - Asian Journal of Cancer 2002; 2 :1.
18. Folkman J, Watson K, Ingber D et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 61 :339.
19. Liotta LA, Steeg PS, Stedet - Stevenson WG. Cancer metastasis and angiogenesis :an imbalance of positive and negative regulation. Cell 1991; 64 :327.
20. Liotta LA, Kleinerman J, Saidel GM. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 1976; 36 :889.
21. Ingber D, Fujita T, Kishimoto S et al. Synthetic analogues of fumagilin that inhibit angiogenesis and suppress tumor growth. Nature 1990; 348 :555.
22. Graca B, Lunet C, Coelho AS et al. Angiogenesis and cancer : from biopathology to therapy. Acta Med Port 2004; 17 :76.
23. Ryska A, Hovorkova E, Skrabkova Z. Angiogenesis in breast carcinoma: Irnmunohistochemical study of 142 cases. Cesk Patol 2001; 37 :91.
24. Gasparini G and Harris AClinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool. J Clin Oncol 1995; 13 :765.
25. Kato T, Kameoka S, Kimura T et al. The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer. Br J Cancer 2003; 88:1900.
26. Gunel N, Akcali C, Loskum U et al. Prognostic importance of tumor angiogenesis in breast carcinoma with adjuvant chemotherapy. Pathol Res Pract 2002 ; 198:7.
27. Erdem O, Dursun A, Coskum U et al. The prognostic value of P53 and c-erb-B2 expression, proliferative activity and angiogenesis in node negative breast carcinoma. Tumori 2005 ; 91:46.
28. Axelsson K, Ljung B, Moore D et al. Tumor angiogenesis as a prognostic assay for invasive ductual breast carcinoma. J Natl Cancer Inst 1995; 87 : 997.
29. Bozcuk H, Uslu G, Pestereli E et al .Predictors of distant metastasis in breast cancer: a study also evaluating associations among common biological. Breast Cancer Res Treat 2001 ; 68:239.
30. Hieken TJ, Farolan M, D'Alessandro S et al.Predicting the biological behaviour of ductual carcinoma in situ, an analysis of molecular markers. Surgery 2001; 130:593.
31. Linderholm BK, Lindahl T, Holmberg L et al. The expression of vascular endothelial growth factor correlates with mutant P53 and poor prognosis in human breast cancer. Cancer Res 2001 ; 61:2256.
32. Linderholm B, Lindh B, Tavelin B et al. P53 and vascular growth factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma . Int J Cancer 2000 ; 89 :51.
33. Nishmura R, Nagao K, Miyayama H et al.High plasma vascular endothelial growth factor levels correlate with menopause, overexpression of P53, and recurrence of breast cancer. Breast Cancer 2003 ;10: 120.
34. Kieser A, Weich HA, Brandner G et al. Mutant P53 potentiates protein kinase induction of vascular endothelial growth factor expression. Oncogene 1994; 9 : 963.
35. Gasparini G, Weinder N, Bevilacpia P et al. Tumor microvessel density, P53 expression, tumor size and peritumoral lymphatic vessel invasion are relevant prognostic markers on node negative breast carcinoma. J Clin Oncol 1994; 12 :454.
36. Tas F, Yavuz E, Aydiner A et al. Angiogenesis and P53 protein expression in breast cancer, prognostic roles and interrelationships. Am J Clin Oncol 2000; 23 : 546 .
37. Shiptz B. Bomstein Y, Sternberg A et al.Angiogenesis P53, and c-erb B 2 immunoreactivity and clinico- pathological features in male breast cancer. J Surg Oncol 2000; 75 :252.
38. Gasparini G, Toi M,Biganzoli E et al. Thrombospondin-1 and -2 in node negative breast cancer:correlation with angiogenic factors, P53 , cathepsin D, hormone receptor and prognosis. Oncology 2001;60:72.
39. Van Hoef ME, Knox WF, Dhesi SS et al.Assessment of tumor vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 1993 ; 29 :1141.
40. Horak ER, Leek R, Klenk N et al. Angiogenesis, assessed by platelet endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992; 340 :1120.